Suven Life Sciences Limited Press Release Jul 10 2026

Suven Life Sciences Limited has informed the Exchange regarding a press release dated July 10, 2026, titled "Suven Life Sciences to Present Five Scientific Posters, Including Global Phase-3 Masupirdine Study Updates and Usmarapride Phase-2 clinical development program at Alzheimer's Association International Conference (A Global Forum to Advance Dementia Science) AAIC-2026 during 12-15 July, 2026 in London, UK.".

View Attachment